Related Experiment Video

Updated: Jun 30, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.1K

Research status and challenges of Mycoplasma pneumoniae pneumonia in children: A bibliometric and visualization

Congcong Liu1, Rui Wang, Shuyi Ge

  • 1Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Medicine
|March 15, 2024
PubMed
Abstract

Insights

This bibliometric analysis reveals Mycoplasma pneumoniae pneumonia research trends in children. China leads global publications, with key institutions and researchers identified, highlighting current research frontiers.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Bibliometrics

Background:

  • Mycoplasma pneumoniae (MP) infections cause regional outbreaks every 3-7 years.
  • A recent surge in MP infections in children in China presents a significant public health challenge.
  • Bibliometric analysis has not been previously applied to studies on MP infection in children.

Purpose of the Study:

  • To conduct a bibliometric analysis of global research on Mycoplasma pneumoniae pneumonia in children.
  • To identify key research trends, prolific institutions, and influential authors in the field.
  • To provide insights for future scientific exploration and clinical applications.

Main Methods:

  • A comprehensive literature search was conducted on Web of Science for English publications from 2011-2023.
  • Bibliometric analysis was performed using VOSviewer and Citespace software.
  • Keyword co-occurrence network analysis was utilized to identify research clusters.

Main Results:

  • 993 articles were published by 5062 authors from 1381 institutions across 75 countries.
  • China dominated global productivity (56.19%), with Soochow University, Capital Medical University, and Zhejiang University as leading institutions.
  • Zhimin Chen (Zhejiang University) had the highest H-index (32); 7 relevant research clusters were identified.

Conclusions:

  • Current research hotspots include MP pneumonia, refractory MP pneumonia, lactate dehydrogenase, asthma, and biomarkers.
  • This study offers novel insights into the scientific landscape of pediatric MP pneumonia.
  • Findings can guide future research directions and clinical management strategies for MP pneumonia in children.

More Related Videos

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.4K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.8K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
233
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
208
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
268
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324